{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:48:59Z","timestamp":1760986139222,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Ataxia with oculomotor apraxia type 1 (AOA1) is a rare genetic disorder and is inherited in an autosomal recessive manner. It is mainly characterized by childhood-onset progressive cerebellar ataxia, with dysarthria and gait disturbance being the two most common and typical manifestations. Axonal sensorimotor peripheral neuropathy, dystonia, chorea, and cognitive impairment are common associated symptoms, as are hypoalbuminemia and hypercholesterolemia. Oculomotor apraxia (OMA)has been reported to be a feature often, although not exclusively, associated with AOA1. The Aprataxin gene, <jats:italic>APTX<\/jats:italic>, is ubiquitously expressed, and numerous APTX mutations are associated with different clinical phenotypes have been found. In the present study, we enrolled a 14-year-old boy who developed ataxia with staggering gait from the age of 4 years. Early-onset cerebellar ataxia, peripheral axonal neuropathy, cognitive impairment and hypoalbuminemia, hypercholesterolemia were presented in this patient, except for OMA. We applied ataxia-related genes filtering strategies and whole-exome sequencing (WES) to discover the genetic factors in a Chinese family. Sanger sequencing was used in the co segregation analysis in the family members. A compound heterozygous mutation in APTX gene (c.739C&amp;gt;T and c.501dupG) was identified. This is the first description of a genetically confirmed patient of AOA1 in a Chinese family in addition to a novel mutation of c.501dupG in APTX.<\/jats:p>","DOI":"10.3389\/fneur.2022.873826","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T10:52:11Z","timestamp":1662115931000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: A novel APTX p.Ser168GlufsTer19 mutation in a Chinese family with ataxia with oculomotor apraxia type 1"],"prefix":"10.3389","volume":"13","author":[{"given":"Xuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhensheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tieyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1056\/NEJMra1006610","article-title":"The autosomal recessive cerebellar ataxias","volume":"366","author":"Anheim","year":"2012","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1212\/WNL.59.4.590","article-title":"Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations","volume":"59","author":"Shimazaki","year":"2002","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/brain\/awr069","article-title":"Genotype-phenotype correlations in early onset ataxia with ocular motor apraxia and hypoalbuminaemia","volume":"134","author":"Yokoseki","year":"2011","journal-title":"Brain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/brain\/awg283","article-title":"Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies","volume":"126","author":"Le Ber","year":"2003","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ng1001-184","article-title":"Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene","volume":"29","author":"Date","year":"2001","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/archneur.58.2.201","article-title":"Recessive ataxia with ocular apraxia: review of 22 Portuguese patients","volume":"58","author":"Barbot","year":"2001","journal-title":"Arch Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng1001-189","article-title":"The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT\/Zn-finger protein aprataxin","volume":"29","author":"Moreira M","year":"2001","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ana.410240404","article-title":"Ataxia-ocular motor apraxia: a syndrome mimicking ataxia-telangiectasia","volume":"24","author":"Aicardi","year":"1988","journal-title":"Ann Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamaneurol.2017.4373","article-title":"Clinical, biomarker, and molecular delineations and genotype-phenotype correlations of ataxia with oculomotor apraxia type 1","volume":"75","author":"Renaud","year":"2018","journal-title":"JAMA Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1128\/MCB.24.19.8356-8365.2004","article-title":"A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment","volume":"24","author":"Luo","year":"2004","journal-title":"Mol Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nature05164","article-title":"The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates Nature","volume":"443","author":"Ahel","year":"2006"},{"key":"B12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/B978-0-444-64189-2.00007-X","article-title":"Nonsyndromic cerebellar ataxias associated with disorders of DNA single-strand break repair","volume":"155","author":"Yoon","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1073\/pnas.1100084108","article-title":"Aprataxin localizes to mitochondria and preserves mitochondrial function","volume":"108","author":"Sykora","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0022-510X(95)00176-3","article-title":"Hereditary motor and sensory neuropathy associated with cerebellar atrophy (HMSNCA): a new disease","volume":"133","author":"Fukuhara","year":"1995","journal-title":"J Neurol Sci."},{"key":"B15","article-title":"Spinocerebellar ataxia with ocular motor apraxia and DNA repair","volume-title":"Neuropathology.","author":"Onodera","year":"2006"},{"key":"B16","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/01.WNL.0000137044.06573.46","article-title":"Aprataxin gene mutations in Tunisian families","volume":"63","author":"Amouri","year":"2004","journal-title":"Neurology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10048-011-0281-x","article-title":"Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients","volume":"12","author":"Castellotti","year":"2011","journal-title":"Neurogenetics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature12824","article-title":"Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity","volume":"506","author":"Tumbale","year":"2014","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00018-004-4441-0","article-title":"The novel human gene aprataxin is directly involved in DNA single-strand-break repair","volume":"62","author":"Mosesso","year":"2005","journal-title":"Cell Mol Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jamaneurol.2014.193","article-title":"Autosomal recessive cerebellar ataxia type 3 due to ANO10 mutations: delineation and genotype-phenotype correlation study","volume":"71","author":"Renaud","year":"2014","journal-title":"JAMA Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13244-011-0086-3","article-title":"New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay","volume":"2","author":"Gasparotti","year":"2011","journal-title":"Insights Imag."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.neuroimage.2012.07.063","article-title":"Direct visualization of cerebellar nuclei in patients with focal cerebellar lesions and its application for lesion-symptom mapping Neuroimage","volume":"63","author":"Maderwald","year":"2012"},{"key":"B23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5334\/tohm.319","article-title":"More than ataxia: hyperkinetic movement disorders in childhood autosomal recessive ataxia syndromes","volume":"6","author":"Pearson","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejrad.2018.11.035","article-title":"A new MRI marker of ataxia with oculomotor apraxia","volume":"110","author":"Ronsin","year":"2019","journal-title":"Eur J Radiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1590\/0004-282x-anp-2021-0065","article-title":"Rehabilitation in patients with cerebellar ataxias","volume":"80","author":"Chien H","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"key":"B26","unstructured":"10.1590\/0004-282X20160038270508552016"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.873826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T10:52:16Z","timestamp":1662115936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.873826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":26,"alternative-id":["10.3389\/fneur.2022.873826"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.873826","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"873826"}}